“…They are spindle‐shaped nucleated cells with multi‐lineage differentiation potential and immune‐modulating ability which most broadly studied for therapeutic potentials. Indeed, BM‐MSCs have been considered as the gold standard for clinical applications (Batsali et al, ), because they are easily extractable, survive better after transplantation and show weak immunogenicity (Husak & Dworzak, ; Liu et al, ; Shin et al, ; Tsuji et al, ; Zeng et al, ). In fact, BM‐MSCs are represented as the cells of origin of osteosarcoma while they are capable of dividing into one of several mesenchymal phenotypes such as osteoblasts, chondrocytes, myocytes, marrow stromal cells, tendon‐ligament fibroblasts, and adipocytes (Caplan & Dennis, ; Tsuji et al, ; He et al, ).…”